Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1992 Jul 25;305(6847):235–240. doi: 10.1136/bmj.305.6847.235

When to stop a clinical trial.

S J Pocock 1
PMCID: PMC1882707  PMID: 1392832

Full text

PDF
235

Images in this article

240FIG 1
on p.240

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dillman R. O., Seagren S. L., Propert K. J., Guerra J., Eaton W. L., Perry M. C., Carey R. W., Frei E. F., 3rd, Green M. R. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med. 1990 Oct 4;323(14):940–945. doi: 10.1056/NEJM199010043231403. [DOI] [PubMed] [Google Scholar]
  2. Fleming T. R., Harrington D. P., O'Brien P. C. Designs for group sequential tests. Control Clin Trials. 1984 Dec;5(4):348–361. doi: 10.1016/s0197-2456(84)80014-8. [DOI] [PubMed] [Google Scholar]
  3. Fleming T. R., Watelet L. F. Approaches to monitoring clinical trials. J Natl Cancer Inst. 1989 Feb 1;81(3):188–193. doi: 10.1093/jnci/81.3.188. [DOI] [PubMed] [Google Scholar]
  4. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987 Jul 16;317(3):141–145. doi: 10.1056/NEJM198707163170304. [DOI] [PubMed] [Google Scholar]
  5. Freedman L. S., Spiegelhalter D. J. Comparison of Bayesian with group sequential methods for monitoring clinical trials. Control Clin Trials. 1989 Dec;10(4):357–367. doi: 10.1016/0197-2456(89)90001-9. [DOI] [PubMed] [Google Scholar]
  6. Geller N. L., Pocock S. J. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. Biometrics. 1987 Mar;43(1):213–223. [PubMed] [Google Scholar]
  7. Hampton J. R., Julian D. G. Role of the pharmaceutical industry in major clinical trials. Lancet. 1987 Nov 28;2(8570):1258–1259. doi: 10.1016/s0140-6736(87)91863-0. [DOI] [PubMed] [Google Scholar]
  8. Henderson W. G., Fisher S. G., Weber L., Hammermeister K. E., Sethi G. Conditional power for arbitrary survival curves to decide whether to extend a clinical trial. Control Clin Trials. 1991 Apr;12(2):304–313. doi: 10.1016/0197-2456(91)90027-j. [DOI] [PubMed] [Google Scholar]
  9. O'Brien P. C., Fleming T. R. A multiple testing procedure for clinical trials. Biometrics. 1979 Sep;35(3):549–556. [PubMed] [Google Scholar]
  10. O'Rourke P. P., Crone R. K., Vacanti J. P., Ware J. H., Lillehei C. W., Parad R. B., Epstein M. F. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics. 1989 Dec;84(6):957–963. [PubMed] [Google Scholar]
  11. Pawitan Y., Hallstrom A. Statistical interim monitoring of the Cardiac Arrhythmia Suppression Trial. Stat Med. 1990 Sep;9(9):1081–1090. doi: 10.1002/sim.4780090915. [DOI] [PubMed] [Google Scholar]
  12. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Pocock S. J., Hughes M. D. Estimation issues in clinical trials and overviews. Stat Med. 1990 Jun;9(6):657–671. doi: 10.1002/sim.4780090612. [DOI] [PubMed] [Google Scholar]
  14. Pocock S. J., Thompson S. G. Primary prevention trials in cardiovascular disease. J Epidemiol Community Health. 1990 Mar;44(1):3–6. doi: 10.1136/jech.44.1.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Volberding P. A., Lagakos S. W., Koch M. A., Pettinelli C., Myers M. W., Booth D. K., Balfour H. H., Jr, Reichman R. C., Bartlett J. A., Hirsch M. S. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med. 1990 Apr 5;322(14):941–949. doi: 10.1056/NEJM199004053221401. [DOI] [PubMed] [Google Scholar]
  16. Ware J. H., Muller J. E., Braunwald E. The futility index. An approach to the cost-effective termination of randomized clinical trials. Am J Med. 1985 Apr;78(4):635–643. doi: 10.1016/0002-9343(85)90407-3. [DOI] [PubMed] [Google Scholar]
  17. Yusuf S., Collins R., Peto R., Furberg C., Stampfer M. J., Goldhaber S. Z., Hennekens C. H. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J. 1985 Jul;6(7):556–585. doi: 10.1093/oxfordjournals.eurheartj.a061905. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES